Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome

计划入组 120 人 · 首次发布于 2008 年 3 月 11 日

A Study of INCB050465 in Primary Sjögren's Syndrome

计划入组 10 人 · 首次发布于 2018 年 8 月 13 日

PD of VAY736 in Patients With Primary Sjögren's Syndrome

计划入组 27 人 · 首次发布于 2014 年 5 月 29 日

gene therapy (AAV, primary Sjogren's syndrome)

Sjogren's syndrome (Precisionlife)

Sjogren's syndrome(ImmuneID)

ALPORT SYNDROME FOUNDATION

United States

PRIMARY PHARMACEUTICALS, INC.

United States

International Rett Syndrome Foundation

United States

Ainos Receives IRB Approval to Study VELDONA® for Sjögren's Syndrome

Servier and Clariness Collaborate on Phase II Trial for Sjögren's Syndrome Drug

Nipocalimab Shows Promise in Phase II Trial for Sjögren's Syndrome